Drug intelligence / Profile preview

CannaWell

Development stage
Preclinical
Lead developer
Cannabis Bioscience International
Modality
Small Molecules
Administration
Oral
01

Overview

CannaWell is a cannabinoid-based therapeutic candidate developed by Cannabis Bioscience International Holdings (CBIH) for the treatment of epilepsy. The formulation is designed to leverage the anticonvulsant properties of phytocannabinoids, primarily by modulating neuronal excitability through the endocannabinoid system and non-canonical receptors. Its mechanism of action likely involves the antagonism of G protein-coupled receptor 55 (GPR55) and the desensitization of transient receptor potential vanilloid 1 (TRPV1) channels, both of which are implicated in seizure activity. CBIH aims to provide standardized, pharmaceutical-grade cannabis extracts to ensure consistent dosing and efficacy in patients with refractory epilepsy.

Brand names
CannaWell
Other names
CannaWell CBDCannaWell Epilepsy
02

Targets

GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on CannaWell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CannaWell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call